Effect of Bladder and Rectum Volume Standardization on Interfractional Dose in Intracavitary (Intrauterine + Paracervical) Brachytherapy of Cervical Cancer

Authors

DOI:

https://doi.org/10.63187/ampas.41

Keywords:

Brachytherapy, Intracavitary, Interfraction, Volume Standardization, Cervical Cancer

Abstract

Purpose: This study evaluated the effect of interfractional bladder and rectum filling on HRCTV and OAR (bladder, rectum, sigmoid) doses in intracavitary brachytherapy for cervical cancer.

Methodology: A retrospective analysis was conducted on CT-simulation images of 25 patients (12 treated with T+O and 13 with T+R applicators). Patients were placed in the dorsal lithotomy position under sedation. A Foley catheter balloon was inflated with 7 cc contrast and the bladder filled with 120 cc of contrast-saline, then clamped. After uterine canal measurement, a suitable T+R or T+O applicator was inserted and fixed by the radiation oncologist. For each patient, new CT-sim images were acquired in the second fraction, and new treatment plans were generated. Dose-volume histograms (DVHs) were analyzed to determine HRCTV (D100, D90) and OAR doses (2cc, 1cc, 0.1cc). Dose variations between fractions were evaluated.

Findings and Conclusion: For the T+O applicator, median HRCTV volumes were 30.76 ± 13.05 cc (first fraction) and 29.24 ± 12.91 cc (second fraction). Bladder, rectum, and sigmoid volumes in the second fraction were 151.38 ± 81.28 cc, 56.94 ± 28.44 cc, and 42.89 ± 33.46 cc, respectively. No significant differences were observed in target or OAR volumes or doses between fractions for either applicator type. Consequently, interfractional organ motion did not significantly affect dose distribution. Therefore, when bladder and rectum volume standardization is achieved, the first fraction plan can be safely used for subsequent treatments.

 

References

-Duane FK, Langan B, Gillham C, et al. Impact of delineation Uncertainties on dose to organs at risk in CT- guided intracavitary brachytherapy. Brachytherapy 2014;13:210-218.

-DeWerd LA, Ibbott GS, Meigooni AS, et al. A dosimetric uncertainty analysis for photon emitting brachytherapy Sources: AAPM Task report Group No. 138 and GEC-ESTRO. Med Phys 2011;38:782-801.

-Kobayashi K, Murakami N, Wakita A, et al. Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy. Radiother Oncol. 2015;117:555-558.

-Andersen ES, Noe KO, Sorensen TS, et al. Simple DVH parameters in addition to comparison to deformable Registration for bladder dose accumulation in cervix cancer brachytherapy. Radiother Oncol 2013;107:52-57.

-Van Heerden LE, van Wieringen N, Koedooder K, Rasch CRN, Pieters BR, Bel A. Dose warping uncertainties for the accumulated Rectal wall dose in cervical cancer brachytherapy. Brachytherapy 2018;17:449-455.

-Chakraborty S, Patel FD, Patil VM, Oinam AS, Sharma SC. Magnitude and implications of interfraction variations in organ doses during high dose rate brachytherapy of cervix cancer: A CT- based planning study. ISRN Oncol 2014: Article ID:687365.

-Jamema SV, Mahantshetty U, Tanderup K, et al. Inter- application Variation of dosage and spatial location of D(2cm(3)) volumes of OARs during MRI imaging based cervix brachytherapy. Radiother Oncol 2013;107:58-62.

-Guler OC., Onal C., Acibuci I. Effects of bladder distension on dose vaginal distribution cuff brachytherapy in patients with endometrial cancer. J Contemp Brachytherapy 2015;6:371-376.

-Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC-ESTRO WorkingGroup (I): Concepts and Terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasison MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235-245.

-Pötter R, Haie -Meder C, Van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and Aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67-77.

-Hellebust TP, Kirisits C, Berger D et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010;96:153-160.

-MTM Davidson, J. Yuen, DP D ' Souza, and DL Batchelar, Image- guided cervix high - dose -rate brachytherapy treatment planning: does custom computed Tomography planning for each insertion provide better conformal avoidance of organs at risk? Brachytherapy 2008; 7(1):37-42.

Downloads

Published

2026-01-19

How to Cite

Okutan, M., Süncak, L., Demir, B., İbiş, K., & Küçücük, S. (2026). Effect of Bladder and Rectum Volume Standardization on Interfractional Dose in Intracavitary (Intrauterine + Paracervical) Brachytherapy of Cervical Cancer. Advances in Medical Pyhsics and Applied Sciences, 2(1), 11–15. https://doi.org/10.63187/ampas.41

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.